Back to top

Xylem downgraded to Neutral from Overweight at JPMorgan

JPMorgan analyst Mark Strouse downgraded Xylem (XYL) to Neutral from Overweight with a price target of $130, down from $140. The firm adjusted rati...

Read full article here »

In-Depth Zacks Research for the Tickers Above

Normally $25 each - click below to receive one report FREE:

Xylem Inc. (XYL)